These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26769876)

  • 1. Alcohol Use Disorder Treatment: The Association of Pretreatment Use and the Role of Drinking Goal.
    Berger L; Brondino M; Fisher M; Gwyther R; Garbutt JC
    J Am Board Fam Med; 2016; 29(1):37-49. PubMed ID: 26769876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
    Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
    Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.
    Gueorguieva R; Wu R; Donovan D; Rounsaville BJ; Couper D; Krystal JH; O'Malley SS
    Alcohol Clin Exp Res; 2011 Mar; 35(3):523-31. PubMed ID: 21143249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
    Mason BJ; Goodman AM; Chabac S; Lehert P
    J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.
    Gueorguieva R; Wu R; Donovan D; Rounsaville BJ; Couper D; Krystal JH; O'Malley SS
    Alcohol; 2012 Mar; 46(2):121-31. PubMed ID: 21925828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of abstinence from heavy drinking during treatment in COMBINE and external validation in PREDICT.
    Gueorguieva R; Wu R; O'Connor PG; Weisner C; Fucito LM; Hoffmann S; Mann K; O'Malley SS
    Alcohol Clin Exp Res; 2014 Oct; 38(10):2647-2656. PubMed ID: 25346505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
    Maisel NC; Blodgett JC; Wilbourne PL; Humphreys K; Finney JW
    Addiction; 2013 Feb; 108(2):275-93. PubMed ID: 23075288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
    Kranzler HR; Gage A
    Am J Addict; 2008; 17(1):70-6. PubMed ID: 18214726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes.
    Subbaraman MS; Metrik J; Patterson D; Swift R
    Addiction; 2017 Apr; 112(4):685-694. PubMed ID: 27865015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acamprosate for alcohol dependence.
    Rösner S; Hackl-Herrwerth A; Leucht S; Lehert P; Vecchi S; Soyka M
    Cochrane Database Syst Rev; 2010 Sep; (9):CD004332. PubMed ID: 20824837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate.
    Gueorguieva R; Wu R; Tsai WM; O'Connor PG; Fucito L; Zhang H; O'Malley SS
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1586-99. PubMed ID: 26141511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of drinking goal on treatment outcome for alcoholism.
    Bujarski S; O'Malley SS; Lunny K; Ray LA
    J Consult Clin Psychol; 2013 Feb; 81(1):13-22. PubMed ID: 23231573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data.
    Mason BJ; Lehert P
    Alcohol Clin Exp Res; 2012 Mar; 36(3):497-508. PubMed ID: 21895717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Abstinence During Early Alcohol Treatment is Significantly Associated with Positive Treatment Outcomes, Independent of Duration of Abstinence.
    Dunn KE; Harrison JA; Leoutsakos JM; Han D; Strain EC
    Alcohol Alcohol; 2017 Jan; 52(1):72-79. PubMed ID: 27567268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
    Poldrugo F
    Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
    Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
    Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.